Collect. Czech. Chem. Commun.
2011, 76, 1549-1566
https://doi.org/10.1135/cccc2011152
Published online 2011-12-22 13:10:35
Conformationally locked nucleoside analogues based on the bridgehead substituted 7-oxonorbornane and their antiviral properties
Milan Dejmeka, Hubert Hřebabeckýa, Martin Dračínskýa, Johan Neytsb, Pieter Leyssenb, Helena Mertlíková-Kaiserováa and Radim Nenckaa,*
a Gilead Sciences & IOCB Research Centre, Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám. 2, 166 10 Prague 6, Czech Republic
b Rega Institute for Medical Research, Minderbroedersstraat 10, BE-3000 Leuven, Belgium
References
1a. Recent reviews: Antiviral Res. 2010, 85, 39.
< T., Ray A. S.: https://doi.org/10.1016/j.antiviral.2009.09.014>
1b. Curr. Med. Chem. 2006, 13, 3675.
< A., Chiacchio M. A., Iannazzo D., Romeo R.: https://doi.org/10.2174/092986706779026110>
2. Marquez V. E. in: Modified Nucleosides: in Biochemistry, Biotechnology and Medicine (P. Herdewijn, Ed.). Wiley–VCH, Weinheim 2008.
3. Antiviral Res. 2006, 71, 268.
< V. E., Hughes S. H., Sei S., Agbaria R.: https://doi.org/10.1016/j.antiviral.2006.04.012>
4a. Chem. Biodivers. 2010, 7, 536.
< R. N., Wengel J.: https://doi.org/10.1002/cbdv.200900343>
4b. Oligonucleotides 2004, 14, 130.
< J. S., Sørensen M. D., Wengel J.: https://doi.org/10.1089/1545457041526317>
5. Curr. Opin. Drug. Discov. Dev. 2009, 12, 876.
C., Chattopadhyaya J.:
6a. Collect. Czech. Chem. Commun. 2005, 70, 519.
< H., Masojídková M., Holý A.: https://doi.org/10.1135/cccc20050519>
6b. Collect. Czech. Chem. Commun. 2007, 72, 1523.
< M., Hřebabecký H., Dračínský M., Holý A.: https://doi.org/10.1135/cccc20071523>
6c. Tetrahedron 2009, 65, 9291.
< M., Hřebabecký H., Dračínský M., Masojídková M., De Palma A. M., Neyts J., Holý A.: https://doi.org/10.1016/j.tet.2009.09.018>
7. Bioorg. Med. Chem. 2010, 18, 4374.
< M., De Palma A. M., Hřebabecký H., Nencka R., Dračínský M., Leyssen P., Neyts J., Holý A.: https://doi.org/10.1016/j.bmc.2010.04.081>
8. Bioorg. Med. Chem. Lett. 2011, 21, 4271.
< M., De Palma A. M., Hřebabecký H., Dejmek M., Dračínský M., Leyssen P., Neyts J., Mertlíková-Kaiserová H., Nencka R.: https://doi.org/10.1016/j.bmcl.2011.05.070>
9a. Tetrahedron 1997, 53, 17115.
< P. S., Chou C. H.: https://doi.org/10.1016/S0040-4020(97)10134-X>
9b. Tetrahedron Lett. 1998, 39, 7381.
< P. S., Tai C. L., Chou C. H.: https://doi.org/10.1016/S0040-4039(98)01601-3>
10. J. Org. Chem. 2007, 72, 7333.
< R. R., Tam W.: https://doi.org/10.1021/jo701383d>
11. Arch. Pharm. 1988, 321, 237.
< H., Cramer G.: https://doi.org/10.1002/ardp.19883210413>